BC
COLL icon

Birchview Capital’s Collegium Pharmaceutical COLL Stock Holding History

Birchview Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-76,768
Closed -$1.39M – 46
2016
Q1 		$1.39M Buy
76,768
+18,000
+31% +$327K 0.99% 9
2015
Q4 		$1.62M Hold
58,768
– – 0.93% 7
2015
Q3 		$1.3M Sell
58,768
-20,000
-25% -$362K 0.84% 10
2015
Q2 		$1.41M Buy
+78,768
New +$1.36M 0.74% 13

Other funds holding COLL

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Birchview Capital's COLL Position: Q2 2016 in Review

Birchview Capital sold out of Collegium Pharmaceutical (COLL) in Q2 2016, closing a stake of 76,768 shares — an estimated $1.39M sold.

Birchview Capital first reported a position in COLL in Q2 2015 and held it in 4 quarters. The position peaked at $1.62M in Q4 2015. 73 funds tracked by Wall St. Rank hold COLL as of Q2 2016.

  • Birchview Capital reported no remaining Collegium Pharmaceutical position as of Q2 2016 after selling out during the quarter.
  • Birchview Capital sold 76,768 Collegium Pharmaceutical shares in Q2 2016, an estimated $1.39M.
  • Birchview Capital first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 4 quarters.
  • Birchview Capital's Collegium Pharmaceutical position peaked at $1.62M in Q4 2015.
  • 73 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2016.

Based on Birchview Capital's 13F filing for Q2 2016, filed 9 Aug 2016.